Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06734156Not Yet Recruiting

CARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal Cancer

Role: lead

NCT06758817Not ApplicableRecruiting

The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)

Role: collaborator

NCT06741293Recruiting

Improving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT)

Role: lead

All 3 trials loaded